Treatment of palmoplantar psoriasis with oral roflumilast: a case series

被引:0
|
作者
Lasheras-Perez, Miguel Antonio [1 ,2 ]
Penuelas-Leal, Rodrigo [3 ]
Sanchez-Carazo, Jose Luis [3 ]
Sahuquillo-Torralba, Antonio Javier [1 ,2 ]
Magdaleno-Tapial, Jorge [3 ]
Torres-Navarro, Ignacio [1 ,2 ]
Unamuno-Bustos, Blanca [1 ,2 ]
Lopez-Davia, Javier [1 ,2 ]
Pujol-Marco, Conrad [1 ,2 ]
Escutia-Munoz, Begona [1 ,2 ]
Botella-Estrada, Rafael [1 ,2 ,4 ]
机构
[1] La Fe Univ & Polytech Hosp, Dept Dermatol, Valencia, Spain
[2] Hlth Res Inst Hosp, La Valencia, Spain
[3] Valencia Gen Hosp, Dept Dermatol, Valencia, Spain
[4] Univ Valencia, Dept Dermatol, Valencia, Spain
关键词
D O I
10.1093/ced/llae229
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Palmoplantar psoriasis (PP) is a particular type of psoriasis that can justify systemic treatment. Roflumilast is a targeted inhibitor of phosphodiesterase-4 that has been recently approved by the US Food and Drugs Administration as a cream for the treatment of plaque psoriasis. In a small randomized clinical trial and single case reports, oral roflumilast has demonstrated efficacy in the treatment of plaque psoriasis. To the best of our knowledge, we present the first case series of patients with PP treated with oral roflumilast.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Successful Treatment of Refractory Palmoplantar Pustular Psoriasis With Apremilast: A Case Series
    Staender, Sascha
    Syring, Felicia
    Ludwig, Ralf J.
    Thaci, Diamant
    FRONTIERS IN MEDICINE, 2020, 7
  • [2] Ustekinumab in the treatment of palmoplantar pustular psoriasis - a case series of nine patients
    Buder, Valeska
    Herberger, Katharina
    Jacobi, Arnd
    Augustin, Matthias
    Radtke, Marc Alexander
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (11):
  • [3] Low dose acitretin versus methotrexate in the treatment of palmoplantar psoriasis: a case series
    Gisondi, P.
    Mattiucci, A.
    Tonin, B.
    Girolomoni, G.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (06) : E246 - E247
  • [4] Commentary: Successful treatment of refractory palmoplantar pustular psoriasis with apremilast: a case series
    Hackley, Madison
    Loesch, Amanda
    Brownstone, Nicholas
    Hsu, Sylvia
    FRONTIERS IN MEDICINE, 2023, 10
  • [5] Successful treatment of recalcitrant hyperkeratotic palmoplantar psoriasis with itolizumab: a case series of three patients
    Chakravadhanula, U.
    Jha, B. K.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E277 - E278
  • [6] Comparative study of oral acitretin and oral methotrexate in the treatment of palmoplantar psoriasis
    Rao, T. N.
    Babu, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 11 - 11
  • [7] Topical roflumilast for the treatment of psoriasis
    Drakos, Anastasia
    Vender, Ron
    Torres, Tiago
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (09) : 1053 - 1062
  • [8] Apremilast in the treatment of palmoplantar pustulosis A case series
    Frischhut, Nina
    Ratzinger, Gudrun
    HAUTARZT, 2021, 72 (03): : 252 - 256
  • [9] Apremilast in treatment of palmoplantar pustulosis - a case series
    Soufila, K. T.
    Thakur, Vishal
    Narang, Tarun
    Dogra, Sunil
    Handa, Sanjeev
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (06) : E247 - E248
  • [10] Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study
    Brunasso, A. M. G.
    Puntoni, M.
    Aberer, W.
    Delfino, C.
    Fancelli, L.
    Massone, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (06) : 1243 - 1251